AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
'Citta Europee e Americane'
Authors: Scalise, G
Citation: G. Scalise, 'Citta Europee e Americane', GRADIVA, (19), 2001, pp. 36-37
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Fineo, A Scalise, G
Citation: A. Giacometti et al., Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture, J ANTIMICRO, 47(1), 2001, pp. 97-99
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections
Authors: Barchiesi, F Di Francesco, LF Arzeni, D Caselli, F Simonetti, O Cellini, A Giacometti, A Offidani, AM Scalise, G
Citation: F. Barchiesi et al., Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections, MYCOPATHOLO, 149(3), 2001, pp. 117-121
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study
Authors: Lepri, AC Phillips, AN Monforte, AD Castelli, F Antinori, A de Luca, A Pezzotti, P Alberici, F Cargnel, A Grima, P Piscopo, R Prestileo, T Scalise, G Vigevani, M Moroni, M
Citation: Ac. Lepri et al., When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study, AIDS, 15(8), 2001, pp. 983-990
In vitro activity of posaconazole against clinical isolates of dermatophytes
Authors: Barchiesi, F Arzeni, D Camiletti, V Simonetti, O Cellini, A Offidani, AM Scalise, G
Citation: F. Barchiesi et al., In vitro activity of posaconazole against clinical isolates of dermatophytes, J CLIN MICR, 39(11), 2001, pp. 4208-4209
Effect of mono-dose intraperitoneal cecropins in experimental septic shock
Authors: Giacometti, A Cirioni, O Ghiselli, R Viticchi, C Mocchegiani, F Riva, A Saba, V Scalise, G
Citation: A. Giacometti et al., Effect of mono-dose intraperitoneal cecropins in experimental septic shock, CRIT CARE M, 29(9), 2001, pp. 1666-1669
Interactions of posaconazole and flucytosine against Cryptococcus neoformans
Authors: Barchiesi, F Schimizzi, AM Najvar, LK Bocanegra, R Caselli, F Di Cesare, S Giannini, D Di Francesco, LF Giacometti, A Carle, F Scalise, G Graybill, JR
Citation: F. Barchiesi et al., Interactions of posaconazole and flucytosine against Cryptococcus neoformans, ANTIM AG CH, 45(5), 2001, pp. 1355-1359
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron
Authors: Ghiselli, R Giacometti, A Goffi, L Cirioni, O Mocchegiani, F Orlando, F Paggi, AM Petrelli, E Scalise, G Saba, V
Citation: R. Ghiselli et al., Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron, J SURG RES, 99(2), 2001, pp. 316-320
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia
Authors: Ghiselli, R Giacometti, A Cirioni, O Orlando, F Mocchegiani, F Pacci, AM Scalise, G Saba, V
Citation: R. Ghiselli et al., Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia, J SURG RES, 100(2), 2001, pp. 183-188
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection
Authors: Ghiselli, R Giacometti, A Goffi, L Cirioni, O Boccoli, G Mocchegiani, F Riva, A Scalise, G Saba, V
Citation: R. Ghiselli et al., Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection, EUR J VAS E, 20(6), 2000, pp. 508-511
Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management
Authors: Clancy, CJ Barchiesi, F DiFrancesco, LF Morris, AJ Snydman, DR Yu, VL Scalise, G Nguyen, MH
Citation: Cj. Clancy et al., Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for management, EUR J CL M, 19(8), 2000, pp. 585-592
A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection
Authors: Floridia, M Tomino, C Bucciardini, R Ricciardulli, D Fragola, V Pirillo, MF Amici, R Giannini, G Galluzzo, CM Andreotti, M Seeber, AC Ammassari, A Cingolani, A Lazzarin, A Scalise, G Cargnel, A Suter, F Milazzo, F Pastore, G Moroni, M Ciammarughi, R Pini, R Carosi, G D'Amato, C Contu, L Concia, E Bonazzi, L Aiuti, F Vigevani, G Vella, S
Citation: M. Floridia et al., A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection, AIDS RES H, 16(17), 2000, pp. 1809-1820
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics
Authors: Giacometti, A Cirioni, O Barchiesi, F Scalise, G
Citation: A. Giacometti et al., In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics, DIAG MICR I, 38(2), 2000, pp. 115-118
Environmental and serological evidence for the presence of toxocariasis inthe urban area of Ancona, Italy
Authors: Giacometti, A Cirioni, O Fortuna, M Osimani, P Antonicelli, L Del Prete, MS Riva, A D'Errico, MM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Environmental and serological evidence for the presence of toxocariasis inthe urban area of Ancona, Italy, EUR J EPID, 16(11), 2000, pp. 1023-1026
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis
Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Mocchegiani, F Riva, A Scalise, G Saba, V
Citation: A. Giacometti et al., Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis, J ANTIMICRO, 46(5), 2000, pp. 751-756
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Paggi, AM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii, J ANTIMICRO, 46(5), 2000, pp. 807-810
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline
Authors: Cirioni, O Giacometti, A Barchiesi, F Scalise, G
Citation: O. Cirioni et al., Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline, J ANTIMICRO, 46(4), 2000, pp. 577-582
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems
Authors: Giacometti, A Cirioni, O Barchiesi, F Ancarani, F Scalise, G
Citation: A. Giacometti et al., In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems, J ANTIMICRO, 45(5), 2000, pp. 651-654
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture
Authors: Giacometti, A Cirioni, O Barchiesi, F Ancarani, F Scalise, G
Citation: A. Giacometti et al., Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture, J ANTIMICRO, 45(4), 2000, pp. 453-456
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines
Authors: Giacometti, A Cirioni, O Barchiesi, F Scalise, G
Citation: A. Giacometti et al., Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines, J ANTIMICRO, 45(3), 2000, pp. 375-377
Primary resistance to flucytosine among clinical isolates of Candida spp.
Authors: Barchiesi, F Arzeni, D Caselli, F Scalise, G
Citation: F. Barchiesi et al., Primary resistance to flucytosine among clinical isolates of Candida spp., J ANTIMICRO, 45(3), 2000, pp. 408-409
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria
Authors: Giacometti, A Cirioni, O Del Prete, MS Paggi, AM D'Errico, MM Scalise, G
Citation: A. Giacometti et al., Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria, PEPTIDES, 21(8), 2000, pp. 1155-1160
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting
Authors: Lamura, T Matthews, RC Barchiesi, F Donahoe, M Burnie, JP Scalise, G
Citation: T. Lamura et al., Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting, J INFECTION, 40(1), 2000, pp. 64-68
Epidemiology and microbiology of surgical wound infections
Authors: Giacometti, A Cirioni, O Schimizzi, AM del Prete, MS Barchiesi, F D'Errico, MM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Epidemiology and microbiology of surgical wound infections, J CLIN MICR, 38(2), 2000, pp. 918-922
Interactions between triazoles and amphotericin B against Cryptococcus neoformans
Authors: Barchiesi, F Schimizzi, AM Caselli, F Novelli, A Fallani, S Giannini, D Arzeni, D Di Cesare, S Di Francesco, LF Fortuna, M Giacometti, A Carle, F Mazzei, T Scalise, G
Citation: F. Barchiesi et al., Interactions between triazoles and amphotericin B against Cryptococcus neoformans, ANTIM AG CH, 44(9), 2000, pp. 2435-2441
Risultati: 1-25 | 26-50 | 51-53